Vbi Vaccines Stock Earnings Per Share
VBI Vaccines fundamentals help investors to digest information that contributes to VBI Vaccines' financial success or failures. It also enables traders to predict the movement of VBI Stock. The fundamental analysis module provides a way to measure VBI Vaccines' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to VBI Vaccines stock.
VBI |
VBI Vaccines Company Earnings Per Share Analysis
VBI Vaccines' Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current VBI Vaccines Earnings Per Share | (3.54) X |
Most of VBI Vaccines' fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, VBI Vaccines is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
CompetitionAccording to the company disclosure, VBI Vaccines has an Earnings Per Share of -3.54 times. This is 142.29% lower than that of the Biotechnology sector and 26.1% lower than that of the Health Care industry. The earnings per share for all United States stocks is notably higher than that of the company.
VBI Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses VBI Vaccines' direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of VBI Vaccines could also be used in its relative valuation, which is a method of valuing VBI Vaccines by comparing valuation metrics of similar companies.VBI Vaccines is currently under evaluation in earnings per share category among its peers.
VBI Fundamentals
| Return On Equity | -4.2 | |||
| Return On Asset | -0.29 | |||
| Operating Margin | (9.68) % | |||
| Current Valuation | 38.92 M | |||
| Shares Outstanding | 28.68 M | |||
| Shares Owned By Insiders | 6.76 % | |||
| Shares Owned By Institutions | 13.00 % | |||
| Number Of Shares Shorted | 276.87 K | |||
| Price To Earning | (3.79) X | |||
| Price To Book | 1.24 X | |||
| Price To Sales | 0.20 X | |||
| Revenue | 8.68 M | |||
| Gross Profit | (10.19 M) | |||
| EBITDA | (53.32 M) | |||
| Net Income | (92.84 M) | |||
| Cash And Equivalents | 82.41 M | |||
| Cash Per Share | 0.32 X | |||
| Total Debt | 53.04 M | |||
| Debt To Equity | 0.32 % | |||
| Current Ratio | 2.29 X | |||
| Book Value Per Share | (0.22) X | |||
| Cash Flow From Operations | (60.88 M) | |||
| Short Ratio | 1.57 X | |||
| Earnings Per Share | (3.54) X | |||
| Target Price | 5.0 | |||
| Number Of Employees | 131 | |||
| Beta | 2.17 | |||
| Market Capitalization | 1.87 M | |||
| Total Asset | 86.95 M | |||
| Retained Earnings | (582.45 M) | |||
| Working Capital | (39.51 M) | |||
| Current Asset | 7.89 M | |||
| Current Liabilities | 3.03 M | |||
| Net Asset | 86.95 M |
About VBI Vaccines Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze VBI Vaccines's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VBI Vaccines using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VBI Vaccines based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in VBI Stock
If you are still planning to invest in VBI Vaccines check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VBI Vaccines' history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |